CD8A and colonic neoplasm: Previous studies have confirmed that targeting FAM-related genes of T cells can promote the antitumour immunity function of CD8+ T cells (58), and the expression of TNFAIP8L3, the gene screened in our study, and the infiltration level of CD8+ T cells can synergistically predict the survival outcomes of colon cancer patients.